GlassScriptPhysician profile
Robert S Unsell
NPI 1568434983
$816.73
in general payments reported to CMS, 2019-2025
15 companies · $27.77 in 2025
The $27.77 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.27 · 2020: $41.04 · 2021: $117 · 2022: $281 · 2023: $176 · 2024: $161 · 2025: $27.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $211.17 | 2022-2024 | Nalu Neurostimulation System |
| Carbofix Orthopedics INC | $103.88 | 2023 | |
| Pavmed INC. | $70.50 | 2021 | |
| Dexcom, INC. | $59.24 | 2022-2023 | Dexcom G6 Transmitter |
| Orthofix Medical, INC. | $49.82 | 2020-2022 | |
| Boston Scientific Corporation | $47.40 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $47.31 | 2022-2023 | Seglentis |
| Horizon Therapeutics Plc | $43.61 | 2019-2020 | |
| Pylant Medical | $33.75 | 2021-2022 | |
| Nevro Corp. | $33.64 | 2024 | Senza |
| Si-Bone, INC. | $31.98 | 2024 | |
| Depuy Synthes Sales INC. | $29.33 | 2022 | |
| Averitas Pharma INC. | $27.77 | 2025 | Qutenza |
| Abbott Laboratories | $14.78 | 2024 | Eterna |
| Pfizer INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Unsell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.